Cargando…

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

Detalles Bibliográficos
Autores principales:	Xu, Kexin, Wu, Zhenhua Jeremy, Groner, Anna C, He, Housheng Hansen, Cai, Changmeng, Stack, Edward C, Loda, Massimo, Liu, Tao, Morrissey, Colm, Vessella, Robert L, Kantoff, Philip W, Balk, Steven P, Liu, X Shirley, Brown, Myles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600666/ http://dx.doi.org/10.1186/1756-8935-6-S1-O14

Ejemplares similares

Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
por: Kim, Jung, et al.
Publicado: (2018)

Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress
por: Liao, Yiji, et al.
Publicado: (2022)

Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer
por: Han, Wanting, et al.
Publicado: (2022)

Going beyond Polycomb: EZH2 Functions in Prostate Cancer
por: Park, Su H., et al.
Publicado: (2021)

The structure of Polycomb-repressed chromatin in the bithorax complex
por: Bowman, Sarah K, et al.
Publicado: (2013)

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
por: Steele, J C, et al.
Publicado: (2006)

RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
por: Han, Wanting, et al.
Publicado: (2022)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
por: Zhang, Xiaotun, et al.
Publicado: (2011)

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
por: Li, Zhongwu, et al.
Publicado: (2013)

Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
por: Zhang, Q, et al.
Publicado: (2014)

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
por: Nguyen, Holly M., et al.
Publicado: (2013)

The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
por: Gan, Lu, et al.
Publicado: (2018)

The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets
por: Van Dessel, Nele, et al.
Publicado: (2010)

Polycomb repressive complex’s evolutionary conserved function: the role of EZH2 status and cellular background
por: Gall Trošelj, Koraljka, et al.
Publicado: (2016)

A closer look into DNase I hypersensitivity
por: He, Housheng Hansen, et al.
Publicado: (2013)

Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2
por: Long, Yicheng, et al.
Publicado: (2017)

HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014)

EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
por: Mu, Weipeng, et al.
Publicado: (2018)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020)

EZH2 dependent epigenetic landscape in adult T cell leukemia and Tax immortalized cells
por: Fujikawa, Dai, et al.
Publicado: (2015)

Impairment of Lamin A/C-Polycomb crosstalk as a possible epigenetic cause of Emery Dreifuss Muscular Dystrophy (EDMD)
por: Lanzuolo, Chiara
Publicado: (2015)

Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers
por: Coulter, Jonathan B., et al.
Publicado: (2023)

Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver
por: Koike, Hiroyuki, et al.
Publicado: (2014)

The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2016)

Polycomb Repressive Complex 2 Modulation through the Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021)

The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart
por: Mathiyalagan, Prabhu, et al.
Publicado: (2014)

Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
por: Nghiem, Belinda, et al.
Publicado: (2016)

Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
por: Stojic, Lovorka, et al.
Publicado: (2011)

Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics
por: He, Housheng Hansen, et al.
Publicado: (2012)

Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
por: Collinson, Adam, et al.
Publicado: (2016)

Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
por: Schade, Amy E., et al.
Publicado: (2023)

Androgen receptor epigenetics
por: Cai, Changmeng, et al.
Publicado: (2013)

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer
por: Mostaghel, Elahe A., et al.
Publicado: (2021)

Goldilocks meets Polycomb
por: Verrijzer, C. Peter
Publicado: (2022)

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer
por: Coleman, Ilsa M., et al.
Publicado: (2022)

Ezh2 programs T(FH) differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf
por: Li, Fengyin, et al.
Publicado: (2018)

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
por: Puppe, Julian, et al.
Publicado: (2009)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rikdt3vs9n4mudggv1c0jhig22